Skip to main content
. 2017 Jun 20;12(6):e0179862. doi: 10.1371/journal.pone.0179862

Fig 3. Omental fat CM augments pancreatic cancer cell chemoresistance.

Fig 3

(A) XTT assay demonstrating a significant increase in survival of gemcitabine-treated pancreatic cancer cells following incubation with omental CM (P< .05), n = 4; (B and C) Annexin-V/PI FACS analysis demonstrating a marked reduction in gemcitabine-induced apoptosis of PANC-1 (B; P< .05) and MIA-PaCa-2 cells (C; P< .05) pretreated with omental fat CM, n = 5.